A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...

Around 2,500 patients who used liraglutide, marketed as Victoza and Saxenda, had the second lowest risk of hospitalization.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...